Digestive Disease Week (DDW), 2024
Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
U.S. Medical
This site is intended for U.S. Healthcare Professionals.
To report an adverse event or product quality complaint, call 1-877-TAKEDA-7 (1-877-825-3327)
Not an actual patient.
The exact prevalence of SBS is not known due to under-reporting and the lack of reliable patient databases.1 It is estimated that 10,000 to 20,000 people in the U.S. have this condition.4 These figures may underestimate true prevalence since they are based on the number of patients receiving long-term parenteral nutrition and/or intravenous fluid support and do not include patients with well-tolerated resections who do not require this therapy.1,5
There are several indications for resection that may lead to SBS in adults and children.2,3,6,7,8 SBS may arise from congenital malformations or from physiologic or surgical causes, such as Crohn’s disease and trauma. (Note that many of these causes will be the indication for resection that led to SBS). Patients with SBS are a heterogenous group due to large variations in intestinal function and remnant bowel anatomy.
Loss of the structure and function of certain portions of the bowel can impact the hormones (such as GLP-1 and GLP-2) and the surface area needed for absorption.2,8 SBS is not just characterized by the length of the remaining bowel, but the clinical features indicating the inability to maintain nutritional, fluid, and/or electrolyte homeostasis while consuming a normal, healthy diet.1
After bowel resection surgery, the lining of the remaining intestine may change to absorb more nutrients and fluid through a natural process called intestinal adaptation.2,9,10 This process is encouraged by the presence of nutrients in the gut lumen and the release of gut-related hormones—notably GLP-1, GLP-2 and growth hormone. Gastrointestinal adaptation facilitates weaning patients from parenteral nutrition and IV fluid support. However, this process is highly variable and dependent on a patient’s clinical status and remnant anatomy.
Complications in patients with SBS may relate directly to their disease, to consequences of fluid/electrolyte imbalance and malnutrition, and to complications associated with parenteral nutrition.2,11,12,13 Along with physical limitations, many patients may be unable to work — especially those on home parenteral nutrition. Whatever the cause, SBS and the use of parenteral nutrition are associated with significant morbidity.
Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition, and to discuss current topics in clinical applications.
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Large assembly of pharmacy and healthcare professionals dedicated to the issues of managed care pharmacy, offering immersive education sessions and keynote presentations.
Annual global conference for interdisciplinary, clinical nutrition leaders, providing the latest in clinical nutrition research, education, and products.
Annual conference for a multidisciplinary community of practitioners and researchers focusing on inflammatory bowel disease (IBD) by pairing best practices in clinical care with innovative research.
An all-encompassing event providing real-world clinical education, case studies and new evidence-based approaches in IBD management.
Premier event for clinicians and the general public about digestive disorders and the latest trends in GI technology and therapeutics.
Annual event with more than 2,500 members and non-members of the AMCP to engage on the latest innovations and most intentional networking in managed care pharmacy.
Global congress for researchers from around the world to present their findings on gastroenterology and digestive health.
Annual forum for participants to learn about the latest advances in pediatric gastroenterology, hepatology, and nutrition and to discuss current topics in clinical applications.
Annual global congress dedicated to clinical nutrition and metabolism, including basic and clinical research, education, and organization of consensus statements about clinical care.
Annual meeting uncovering cutting-edge research ranging from basic neurogastroenterology, translational and clinical aspects of gastrointestinal motility, and functional disorders.
Bi-annual congress promoting intestinal rehabilitation and transplantation as a safe, innovative science involving nutritional, medical, surgical and transplant therapies through education, policy development and research.
Annual congress discussing innovative treatments and research discoveries to enhance the standards of care for patients and help pediatric gastroenterology, hepatology, and nutrition professionals improve their practice.
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Global meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
Annual global conference for interdisciplinary, clinical nutrition leaders, providing the latest in clinical nutrition research, education, and products.
Medication Resources
(teduglutide)